Wall Street has been piling in to an area in healthcare you’ve likely never heard of.
Contract research organizations, or CROs for short, work with drugmakers to take on some of the science companies have to do to get drugs approved.
That means everything from discovering potential drug targets to running clinical trials on behalf of pharmaceutical companies.
